Mental health status among COVID-19 patients survivors of critical illness in Saudi Arabia: A 6-month follow-up questionnaire study

Table 3 Multivariable ordered logistic regression for a factor associated with Hospital Anxiety and Depression Scale (n = 48)

Variable	Odds ratio (95%CI)	P value
Age	1.007 (0.955–1.061)	NS
Gender	1.294 (0.275–6.098)	NS
APACHEII	0.919 (0.790–1.069)	NS
Cardiovascular diseases	0.963 (0.206–4.496)	NS
Respiratory diseases	0.084 (0.005–1.542)	NS
Endocrine diseases	0.550 (0.123–2.453)	NS
Renal diseases	0.165 (0.001–32.99)	NS
Autoimmune/Inflammatory diseases	0.721 (0.040–12.95)	NS
Hematological diseases	0.067 (0.001–8.979)	NS
Oxygen support	6.119 (0.418–89.63)	NS
Non-invasive mechanical ventilation	1.082 (0.025–46.40)	NS
Mechanical ventilation	0.042 (0.0001–10.47)	NS
Corticosteroid use	0.094 (0.006–1.420)	NS
Vasopressor use	39.06 (1.309–1165.8)	< 0.05
Tocilizumab use	1.783 (0.215–14.81)	NS

HADS: Hospital anxiety and depression scale; NS: Non-significant; APACHE II: Acute physiology and chronic health evaluation.